1. Losa M, Mortini P, Barzaghi R, Ribotto P, Terreni MR, Marzoli SB, et al. Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. J Neurosurg 2008;108:525-32.
[CROSSREF] [PUBMED]
2. Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;336:285-8.
[CROSSREF] [PUBMED]
3. Bates AS, Van’t Hoff W, Jones PJ, Clayton RN. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 1996;81:1169-72.
[CROSSREF] [PUBMED]
4. Erfurth EM, Bengtsson BA, Christiansen JS, Bulow B, Hagmar L. Premature mortality and hypopituitarism. Lancet 2001;357:1972.
[CROSSREF]
5. Olsson DS, Nilsson AG, Bryngelsson IL, Trimpou P, Johannsson G, Andersson E. Excess mortality in women and young adults with nonfunctioning pituitary adenoma: a Swedish nationwide study. J Clin Endocrinol Metab 2015;100:2651-8.
[CROSSREF] [PUBMED]
6. Lindholm J, Nielsen EH, Bjerre P, Christiansen JS, Hagen C, Juul S, et al. Hypopituitarism and mortality in pituitary adenoma. Clin Endocrinol (Oxf) 2006;65:51-8.
[CROSSREF] [PUBMED]
7. O’Reilly MW, Reulen RC, Gupta S, Thompson CA, Dineen R, Goulden EL, et al. ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centres. Clin Endocrinol (Oxf) 2016;85:748-56.
[CROSSREF] [PUBMED] [PMC]
8. Sherlock M, Reulen RC, Alonso AA, Ayuk J, Clayton RN, Sheppard MC, et al. ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J Clin Endocrinol Metab 2009;94:4216-23.
[CROSSREF] [PUBMED]
9. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996;17:354-81.
[PUBMED]
10. Rajendra Acharya U, Paul Joseph K, Kannathal N, Lim CM, Suri JS. Heart rate variability: a review. Med Biol Eng Comput 2006;44:1031-51.
[CROSSREF] [PUBMED]
11. Sim SY, Joo KM, Kim HB, Jang S, Kim B, Hong S, et al. Estimation of circadian body temperature rhythm based on heart rate in healthy, ambulatory subjects. IEEE J Biomed Health Inform 2017;21:407-15.
[CROSSREF]
12. Kim HS, Yoon KH, Cho JH. Diurnal heart rate variability fluctuations in normal volunteers. J Diabetes Sci Technol 2014;8:431-3.
[CROSSREF] [PUBMED] [PMC]
13. Park S, Kim WJ, Cho NJ, Choi CY, Heo NH, Gil HW, et al. Predicting intradialytic hypotension using heart rate variability. Sci Rep 2019;9:2574.
[CROSSREF] [PUBMED] [PMC]
14. Tarvainen MP, Niskanen JP, Lipponen JA, Ranta-Aho PO, Karjalainen PA. Kubios HRV: heart rate variability analysis software. Comput Methods Programs Biomed 2014;113:210-20.
[PUBMED]
15. Bilchick KC, Berger RD. Heart rate variability. J Cardiovasc Electrophysiol 2006;17:691-4.
[CROSSREF] [PUBMED]
16. Kim SY. Diagnosis and treatment of hypopituitarism. Endocrinol Metab (Seoul) 2015;30:443-55.
[CROSSREF] [PUBMED] [PMC]
17. Melmed S. Williams textbook of endocrinology. 14th ed. Philadelphia: Elsevier Saunders; 2019. p. 184-235.
18. Billman GE. Heart rate variability: a historical perspective. Front Physiol 2011;2:86.
[PUBMED] [PMC]
19. Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 2013;369:362-72.
[CROSSREF] [PUBMED]
20. Adler GK, Bonyhay I, Failing H, Waring E, Dotson S, Freeman R. Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control. Diabetes 2009;58:360-6.
[CROSSREF] [PUBMED] [PMC]
21. Soydan N, Bretzel RG, Fischer B, Wagenlehner F, Pilatz A, Linn T. Reduced capacity of heart rate regulation in response to mild hypoglycemia induced by glibenclamide and physical exercise in type 2 diabetes. Metabolism 2013;62:717-24.
[CROSSREF] [PUBMED]
22. Silva TP, Rolim LC, Sallum Filho C, Zimmermann LM, Malerbi F, Dib SA. Association between severity of hypoglycemia and loss of heart rate variability in patients with type 1 diabetes mellitus. Diabetes Metab Res Rev 2017;33:e2830.
[CROSSREF]
23. De Ferrari GM, Sanzo A, Bertoletti A, Specchia G, Vanoli E, Schwartz PJ. Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. J Am Coll Cardiol 2007;50:2285-90.
[CROSSREF]
24. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007;115:387-97.
[CROSSREF] [PUBMED]
25. Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 2003;26:1895-901.
[CROSSREF]
26. Hassan-Smith ZK, Sherlock M, Reulen RC, Arlt W, Ayuk J, Toogood AA, et al. Outcome of Cushing’s disease following transsphenoidal surgery in a single center over 20 years. J Clin Endocrinol Metab 2012;97:1194-201.
[CROSSREF] [PUBMED]
27. Nilsson B, Gustavasson-Kadaka E, Bengtsson BA, Jonsson B. Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J Clin Endocrinol Metab 2000;85:1420-5.
[CROSSREF] [PUBMED]
28. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001;357:425-31.
[PUBMED]
29. Hannon MJ, Crowley RK, Behan LA, O’Sullivan EP, O’Brien MM, Sherlock M, et al. Acute glucocorticoid deficiency and diabetes insipidus are common after acute traumatic brain injury and predict mortality. J Clin Endocrinol Metab 2013;98:3229-37.
[CROSSREF] [PUBMED]
30. Burman P, Mattsson AF, Johannsson G, Hoybye C, Holmer H, Dahlqvist P, et al. Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality. J Clin Endocrinol Metab 2013;98:1466-75.
[CROSSREF] [PUBMED]
31. Petersons CJ, Mangelsdorf BL, Thompson CH, Burt MG. Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency. J Clin Endocrinol Metab 2014;99:2269-76.
[CROSSREF] [PUBMED]
32. Zueger T, Kirchner P, Herren C, Fischli S, Zwahlen M, Christ E, et al. Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma. J Clin Endocrinol Metab 2012;97:E1938-42.
[CROSSREF] [PUBMED]
33. Comunello A, Dassie F, Martini C, De Carlo E, Mioni R, Battocchio M, et al. Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues. Pituitary 2015;18:525-34.
[CROSSREF] [PUBMED]
34. Berntson GG, Bigger JT Jr, Eckberg DL, Grossman P, Kaufmann PG, Malik M, et al. Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology 1997;34:623-48.
[CROSSREF] [PUBMED]